FDA Approves Reportedly Cheaper Rival To EpiPen
The FDA recently approved a new epinephrine injection, called Symjepi, for emergency treatment of allergic reactions; the news means that consumers may soon have another, potentially cheaper, alternative to EpiPen. Symjepi provides two pre-filled single doses of epinephrine to use for immediate treatment of potentially life-threatening anaphylactic reactions, Drug Discovery & Development reported. In addition to…
Utah Standard News depends on the support of readers like you.
Good Journalism requires time, expertise, passion and money. We know you appreciate the coverage here. Please help us to continue as an alternative news website by becoming a subscriber or making a donation. To learn more about our subscription options or make a donation, click here.
To Advertise on UtahStandardNews.com, please contact us at: ed@utahstandardnews.com.
Comments - No Responses to “FDA Approves Reportedly Cheaper Rival To EpiPen”
Sure is empty down here...